WebJun 17, 2024 · Alfasigma will be responsible for securing regulatory approval in other territories not covered by EMA or MHRA approvals, and for obtaining and maintaining regulatory approvals necessary to... Web7 hours ago · I 33 esuberi della Sofar, a detta di Alfasigma, sono appunto dovuti al processo d'integrazione delle due società. “Non c’è accordo sugli esuberi, le prospettive …
Alfasigma: la farmaceutica abbraccia la sostenibilità - YouTube
WebFeb 5, 2024 · Dublin, Ireland – 5 February 2024: Cosmo Pharmaceuticals NV (SIX: COPN) today announced that it has licensed the EU rights (plus Switzerland, UK, EEA countries, Russia and Mexico) for Lumeblue™ to Alfasigma S.p.A. Lumeblue™ is Cosmo’s recently EMA approved drug for the detection of lesions during colonoscopy. Alfasigma, a private … WebJun 30, 2024 · Alfasigma USA, Inc. Jun 30, 2024, 08:00 ET. COVINGTON, La., June 30, 2024 /PRNewswire/ -- Alfasigma USA, Inc. announces the withdrawal of the NDA for ZELNORM ® (tegaserod) effective June 30th ... inspiring lives new hampton
Alfasigma USA Acquires ZELNORM™ (tegaserod) for …
WebTesi sul marketing sostenibile e CSR. Sostenibilità come valore e obiettivo aziendale a cui tendere: uno storytelling cross channel per comunicare l’impegno aziendale e avvicinare i consumatori al percorso di sostenibilità. Temi affrontati durante il master: • Sviluppo Sostenibile e Agenda 2030. • Responsabilità sociale d'impresa. WebAug 2, 2024 · August 2, 2024 ALFASIGMA S.p.A. has signed an agreement to acquire the entire share capital of SOFAR S.p.A., an Italian pharmaceutical company with over half a century of operational history in the research, production and marketing of drugs, medical devices and food supplements. http://www.ipharminc.com/press-release/2024/7/22/innovation-pharmaceuticals-announces-license-agreement-with-alfasigma-spa-for-the-development-and-commercialization-of-brilacidin-in-ulcerative-proctitis-ulcerative-proctosigmoiditis jet flip top benchtop machine table 728200